Other Industries
Aurora Cannabis reiterates revenue outlook for Q4, FY19
Cannabis producer Aurora Cannabis (NYSE: ACB) reiterated its production and revenue guidance for the fourth quarter and fiscal 2019 after…
Alnylam Pharmaceuticals posts narrower-than-expected Q2 loss
Alnylam Pharmaceuticals (NASDAQ: ALNY) reported a wider loss in the second quarter of 2019 due to higher costs and expenses.…
Vericel reports Q2 earnings beat, raises outlook
Vericel Corporation (NASDAQ: VCEL) reported better-than-expected results in the second quarter aided by strong growth from both of its products.…
Allergan tops Q2 views; lifts 2019 revenue outlook
Allergan plc (NYSE: AGN) surpassed market's expecations for Q2. The company also lifted its revenue outlook for full-year 2019. Non-GAAP…
Regeneron Q2 earnings, revenue top expectations on strong product sales
Regeneron Pharmaceuticals (NASDAQ: REGN) reported an increase in earnings for the second quarter, when revenues grew by 20% helped by…
Marriott Q2 earnings in line with estimates, but revenue fails to impress
Marriott International (NASDAQ: MAR) stock slipped about 3% after the bell as the second quarter earnings came in line with…